Although this year's enrollment period has gone far smoother compared to the first year, there is much room for improvement particularly when it comes to helping consumers make informed decisions, according to a report commissioned by the National Partnership for Women & Families.
Although this year’s enrollment period has gone far smoother compared to the first year, there is much room for improvement particularly when it comes to helping consumers make informed decisions, according to a report commissioned by the National Partnership for Women & Families.
The Supporting Informed Decision-Making in the Health Insurance Marketplace report reviewed all 15 Marketplace websites (14 state-run and HealthCare.gov) to assess performance on 4 key features for informed decision making: enhanced anonymous browsing; direct access to key plan features; useful plan display and availability of consumer tools; and easy website navigation and links for assistance.
For each of these values, the report offered specific substantive and procedural steps that could improve consumers’ plan selection. According to the researchers, while there are more effective smart tools and interactive features on Marketplace websites, they are the exception, not the rule.
“Healthcare reform has given millions of people access to quality, affordable health plans—for many, for the first time,” said National Partnership President Debra L. Ness. “Certainly, it is the greatest advance for women’s health in a generation. But we must also make it as easy as possible for consumers to compare coverage options and identify the plan that best meets their families’ needs. We need to continuously improve the marketplace websites for that to happen.”
Although shopping for a health plan is still too confusing for many consumers, there are many positives thanks to the Affordable Care Act, according to Lauren Birchfield Kennedy, director of health policy at the National Partnership.
“We found many promising practices that enhance transparency in the marketplace and support informed decision-making by consumers,” she said. “Anonymous browsing has become standard practice. Marketplace websites are starting to allow consumers to tailor their searches to align with their circumstances and preferences.”
Nearly all Marketplace websites allow consumers to “window-shop” for plans, which allows for anonymous browsing. Even while browsing anonymously, some Marketplaces still offer smart tools, such as highlighting silver-level plans for anonymous consumers who appear eligible for cost-sharing reductions or a tool that provides customized plan options based on the consumers’ noted preferences.
“Across marketplace websites, there are strong features in place that support informed consumer decision-making,” according to the report. “However, marketplace administrators should continue to look for ways to systematically review and improve how they help consumers analyze and select plans.”
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Understanding How Fitness Affects Digestive Diseases
April 18th 2025Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk, and relieve constipation, while intense workouts may backfire, causing reflux, GI bleeding, or gut barrier disruption.
Read More
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
April 18th 2025Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Read More